Showing results (161-170 of 254) with videos related to
Sort By:
Pageof 26
Kidney International|December 11, 2014
Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitusDaniela Dunkler, Maria Kohl, Georg Heinze, et al.Viruses|August 26, 2023
Monitoring of Sotrovimab-Levels as Pre-Exposure Prophylaxis in Kidney Transplant Recipients Not Responding to SARS-CoV-2 VaccinesConstantin Aschauer, Andreas Heinzel, Karin Stiasny, et al.Nature Genetics|October 31, 2023
A pan-tissue survey of mosaic chromosomal alterations in 948 individualsTeng Gao, Maria Eleni Kastriti, Viktor Ljungström, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapyMoritz Muckenhuber, Jasmin Mucha, Konstantinos Mengrelis, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 16, 2015
Risk Prediction for Early CKD in Type 2 DiabetesDaniela Dunkler, Peggy Gao, Shun Fu Lee, et al.Frontiers in Medicine|June 27, 2022
Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination-A Non-randomized, Controlled Pilot StudyFlorina Regele, Andreas Heinzel, Karin Hu, et al.Methods in Molecular Biology (Clifton, N.J.)|March 4, 2011
Omics-bioinformatics in the context of clinical dataGert Mayer, Georg Heinze, Harald Mischak, et al.Kidney International|July 16, 2015
Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changesPetra Hrubá, Irena Brabcová, Faikah Gueler, et al.Journal of Hypertension|September 5, 2020
Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart diseaseGernot Pichler, Josep Redon, Fernando Martínez, et al.Frontiers in Medicine|November 16, 2020
Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell TransplantationAmmon Handisurya, Nina Worel, Werner Rabitsch, et al.Pageof 26